Latta, Griffith’s HALT Fentanyl Act approved by Energy and Commerce Committee


WASHINGTON, D.C. – Last week, through a bipartisan vote, the House Energy and Commerce Committee approved the HALT Fentanyl Act – legislation led by Congressman Bob Latta, R-Bowling Green, and Congressman Morgan Griffith (R-VA9) – to address the permanent scheduling of fentanyl analogues.

It will now head to the House floor for a vote.

“In just one year, lethal fentanyl poisonings claimed the lives of over 5,000 Ohioans and more than 70,000 Americans,” Latta said. “It is clear that swift action is needed to stem this crisis. Today, the Energy and Commerce Committee did just that by advancing the HALT Fentanyl Act, legislation I’m co-leading with my colleague, Rep. Morgan Griffith. This bill is key to saving lives by helping eradicate the scourge of fentanyl that has infiltrated our communities in Ohio and beyond. I look forward to its next stop: a vote before the U.S. House of Representatives.”

Currently, fentanyl and fentanyl analogues temporarily fall under Schedule I of the Controlled Substances Act due to a temporary scheduling order that runs through Dec. 31, 2024.

The HALT Fentanyl Act would permanently place fentanyl analogues into Schedule I of the CSA, simplify registration processes for certain research with Schedule I substances, remove barriers that currently impede such work, and provide for exemption of individual analogues from Schedule I when evidence demonstrates it is appropriate.

No posts to display